Robaxin (methocarbamol)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Methocarbamol is a centrally acting skeletal muscle relaxant.
USES: This medication is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It may work by causing drowsiness and helping to relax the muscles.
Generic name: methocarbamol
Pronunciation: (METH-oh-KAR-ba-mol)
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Robaxin
Indications
The following indications are listed for Robaxin:
- Muscle Spasm
- Tetanus Adjunct Treatment
Also known as: Adjunct Medication Therapy For Tetanus, Adjunct Treatment Of Tetanus, Involuntary Muscle Contraction, Muscle Spasticity, Skeletal Muscle Spasm, Spasticity.
Dosing
No dosing information is available for this tab.
Methocarbamol is usually administered orally. When oral methocarbamol therapy is not feasible or in patients with severe musculoskeletal pain, the drug may be given IM or IV. Methocarbamol injection should not be administered subcutaneously.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
It is not known whether methocarbamol can cause fetal harm or affect reproductive capacity. Animal reproductive studies have not been performed; however, there have been reports of fetal and congenital abnormalities following in utero exposure to the drug. Methocarbamol should not be used during pregnancy, particularly during early pregnancy, unless the potential benefits justify the possible risks to the fetus.
Methocarbamol is distributed into milk in dogs; however, it is not known whether the drug or its metabolites are distributed into human milk. Methocarbamol should be used with caution in nursing women.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.